Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 Slide Shows
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
CES 2010 Coverage 

Follow Us
RTTNews on Twitter RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube

Font Down Font Up

 
Dionex Q2 Profit Down, Guides Q3, Revises FY10 Outlook - Update
2/9/2010 8:13 PM  ET
RELATED NEWS
Dionex Q2 Profit Declines; Guides Q3; Revises FY10 Guidance - Quick Facts
Dionex Corp. Is Rising Following Q2 Report
Dionex Q2 10 Earnings Conference Call At 4:30 PM ET
Dionex Corporation To Present At The 28th Annual J.P. Morgan Healthcare Conference At 12:30 PM ET

Trade DNEX now with
TOP MARKET NEWS
Baidu Q4 Profit Up 48.2%; Guides Q1 Revenue Above Estimates
IMS Health Profit Declines 27%
Cerner Earnings Decline, Top Estimates
Disney Profit Tops Estimate
XL Capital Posts Narrower Loss In Q4 - Update
(RTTNews) -  Tuesday, analytical instrumentation and chemical company Dionex Corp. (DNEX: News ), posted a modest decrease in profit for the second quarter on higher operating costs, despite an increase in revenue. The company also provided its guidance for the third quarter, while revising full year forecast.

Dionex's second-quarter profit decreased to $16.58 million or $0.92 per share from $17.02 million or $0.93 per share a year ago. Results for the quarter included a one-time charge of approximately $0.70 million, net of tax, related to the write-up of inventory in the acquisition of the ESA Life Sciences Tools business and a discrete tax benefit of approximately $0.90 million related to a favorable tax audit outcome.

Analysts polled by Thomson Reuters expected earnings of $0.88 per share for the quarter. Analysts' estimates typically exclude one-time items.

Net sales increased 6% to $109.2 million from $103.0 million last year, above analysts estimate of $108.90 million. Currency fluctuations increased second-quarter sales by $7.5 million or 7% this quarter, compared to the year ago, while sales from the ESA acquisition added an additional $4.1 million to consolidated sales for the quarter.

The company said that it met with higher global demand for its environmental, life sciences, food, beverage and electronics products. It also reported a low-single digit sales growth in ion chromatography during the quarter as North America and Europe continued to be difficult markets, offset by growth in the Asia/Pacific segment.

Operating expenses increased to $48.15 million from $43.65 million due to the effect of currency fluctuations, the on-going expenses associated with the ESA business, acquired in September, and costs related to Oracle implementation in Europe. Selling, general and administrative expenses rose to $40.50 million from $36.20 million and R&D costs increased to $7.65 million from $7.45 million.
For the six-month period, Dionex net income decreased to $26.91 million or $1.49 per share from $28.84 million or $1.57 per share a year ago. Sales for period decreased to $199.82 million from $196.47 million.

Looking ahead, Dionex said it expects third-quarter earnings of $0.90 to $0.93 per share, on net sales between $109 million and $113 million. Analysts currently expect third-quarter earnings of $0.86 on revenue of $105.98 million.

For the full year, the company raised its revenue guidance to a range of $413 million to $420 million and earnings in the range of $3.15 to $3.23 per share. Analysts currently expect full-year earnings of $3.70 on revenue of $437.00 million for the year.

To receive FREE breaking news email alerts for Dionex Corp. and others in your portfolio


 1   2   Next Page 


Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print           Follow Us RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube

     
 

More Breaking News-US

102  HNI Slips To Loss In Q4 - Update
101  Terreno Realty Prices 8.75 Mln Common Shares IPO At $20/share - Update
100  RenaissanceRe Holdings Swings To Profit In Q4 - Update
99  Aspen Insurance Holdings Q4 Profit Surges, Tops View - Update
98  Gildan Activewear Q1 Profit Surges; Backs FY10 Outlook - Update
97  Max Capital Group Swings To Q4 Profit - Update
96  Airgas Rejects Air Products' Hostile Takeover Bid - Update
95  American Financial Group Q4 Profit Rises, Tops Estimate, Lifts FY10 Earnings View - Update
94  Seattle Genetics Posts Narrower Q4 Loss - Update
93  AspenTech Swings To Q2 Loss - Update
92  Corrections Corp. Q4 Profit Rises - Update
91  Kforce Swings To Profit In Q4; Guides Q1 - Update
90  RealNetworks, MTV To Spin Off Rhapsody - Update
89  Netgear Turns To Profit In Q4 - Update
88  Healthcare Services Group Q4 Profit Declines - Update
  

 

Copyright © 2010 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service| How To Use RTTNews.com| Advertise| Privacy| Buy Content | RSS